Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Ureteric cancer
ADR ID BADD_A04429
ADR Hierarchy
20      Renal and urinary disorders
20.06      Ureteric disorders
20.06.01      Ureteric disorders NEC
20.06.01.008      Ureteric cancer
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.08      Renal and urinary tract neoplasms malignant and unspecified
16.08.05      Renal pelvis and ureter neoplasms malignant
16.08.05.002      Ureteric cancer
Description Cancer or tumors of the URETER which may cause obstruction leading to hydroureter, HYDRONEPHROSIS, and PYELONEPHRITIS. HEMATURIA is a common symptom. [MeSH]
MedDRA Code 10046392
MeSH ID D014516
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Malignant neoplasm of ureter | Ureter cancer | Ureteral cancer | Ureteric cancer | Ureteric cancer NOS | Ureteral Neoplasms | Neoplasm, Ureteral | Ureteral Neoplasm | Neoplasms, Ureteral | Ureter Neoplasms | Ureter Neoplasm | Neoplasms of Ureter | Cancer of Ureter | Ureter Cancers | Ureter, Cancer Of | Ureter Cancer | Ureteral Cancer | Cancer, Ureteral | Cancers, Ureteral | Ureteral Cancers | Cancer of the Ureter
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00474Cisplatin0.000112%
BADD_D00549Cyclophosphamide--
BADD_D00551Cyclosporine0.000111%
BADD_D01567Nilotinib0.000112%
BADD_D01777Pioglitazone0.000386%
BADD_D01913Ranitidine0.000063%
BADD_D01971Rosuvastatin0.000026%
BADD_D02105Tacrolimus0.000446%
The 1th Page    1    Total 1 Pages